DiaUnion at the 5th Childhood Diabetes Prevention Symposium
Last week FDA approved the teplizumab drug (Tzield™) that has delayed the onset of type 1 diabetes (T1D) for up 7 years in clinical trials… Read More »DiaUnion at the 5th Childhood Diabetes Prevention Symposium